Skip to main content

John Paulson's Merger Fund Had A Nice Little Quarter

April has also worked out well for JP.
  • Author:
  • Updated:

Billionaire John Paulson’s merger strategy has gained 10 percent this year lifted by consolidation among drugmakers. The $19.3 billion New York-based firm posted a 0.7 percent return last month in a merger fund that uses leverage to amplify gains, according to three people familiar with the matter, who asked not to be identified because the information is private. An unlevered version rose 0.3 in March and is up 4.5 percent this year. [Bloomberg]


Whatever Doesn't Kill John Paulson Makes Him Stronger

At this point, the hedge fund manager could bench press a dozen Bloomberg terminals.